0001140361-18-014330.txt : 20180320 0001140361-18-014330.hdr.sgml : 20180320 20180320172751 ACCESSION NUMBER: 0001140361-18-014330 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180316 FILED AS OF DATE: 20180320 DATE AS OF CHANGE: 20180320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Li Yvonne CENTRAL INDEX KEY: 0001735045 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 18702701 MAIL ADDRESS: STREET 1: C/O ONCOMED PHARMACEUTICALS, INC. STREET 2: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 3 1 doc1.xml FORM 3 X0206 3 2018-03-16 0 0001302573 OncoMed Pharmaceuticals Inc OMED 0001735045 Li Yvonne C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 0 1 0 0 See Remarks Common Stock 64952 D Stock Option (Right to Buy) 3.42 2018-12-04 Common Stock 1017 D Stock Option (Right to Buy) 8.55 2023-03-14 Common Stock 15571 D Stock Option (Right to Buy) 17 2023-07-16 Common Stock 5000 D Stock Option (Right to Buy) 21.18 2024-12-17 Common Stock 35000 D Stock Option (Right to Buy) 21.43 2025-12-26 Common Stock 30000 D Stock Option (Right to Buy) 7.66 2027-01-02 Common Stock 45000 D Stock Option (Right to Buy) 3.73 2027-04-22 Common Stock 50000 D Stock Option (Right to Buy) 4.36 2027-10-06 Common Stock 26666 D Stock Option (Right to Buy) 3.98 2028-01-03 Common Stock 55000 D Includes 45,834 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. The option is fully vested and exercisable. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of December 18, 2014, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of December 27, 2015, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of January 3, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 23, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of October 7, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of January 4, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Vice President, Finance, Controller and Administration /s/ Alicia J. Hager, Attorney-in-Fact for Yvonne Li 2018-03-20